How much does Enruining (Dexrazoxane for Injection) Cost& price without insurance in China?
Enruining® is the commercial brand name of Dexrazoxane for Injection, a cardioprotective agent developed by Gland Pharma Limited. It acts as a free radical scavenger and iron chelator, reducing anthracycline-induced cardiac toxicity by preventing the formation of iron-doxorubicin complexes that generate reactive oxygen species.
Main Indications
Reduction of the incidence and severity of anthracycline-induced cardiotoxicity in adult patients with advanced/metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m² or more and require continued doxorubicin therapy.
Common Side Effects
Common mild adverse reactions: Nausea, vomiting, fatigue, fever, and injection site reactions.
Laboratory abnormalities: Leukopenia, neutropenia, thrombocytopenia, and anemia.
Severe but uncommon risks: Severe myelosuppression, severe hypersensitivity reactions, and secondary malignancies.
Approval Status in China
Enruining® (Dexrazoxane for Injection, 500mg per vial) was officially approved for marketing in China in 2023. It is currently a prescription cardioprotective drug.
Buy Enruining (Dexrazoxane for Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
